TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 73 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $10,927,000 | +23.9% | 810,000 | 0.0% | 1.38% | +41.7% |
| Q1 2014 | $8,821,000 | -27.5% | 810,000 | -10.0% | 0.98% | -25.1% |
| Q4 2013 | $12,168,000 | +18.8% | 900,000 | 0.0% | 1.30% | +3.7% |
| Q3 2013 | $10,242,000 | +61.9% | 900,000 | 0.0% | 1.26% | +47.4% |
| Q2 2013 | $6,327,000 | – | 900,000 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |